Gestational diabetes: screening, diagnosis and management
Screen at 24–28 weeks with the two-step test, diagnose on two or more abnormal values, then step up treatment from lifestyle to drugs only when targets are missed.
Describe screening for gestational diabetes and the stepwise management from lifestyle to pharmacotherapy.
The short version
- Screen everyone at 24–28 weeks: a 50 g load with a 1-hour glucose, then, if positive, a 100 g, 3-hour test to confirm.
- On the 100 g test, two or more values at or above the Carpenter-Coustan limits (95, 180, 155, 140 mg/dL) make the diagnosis.
- Management is stepwise: lifestyle first, then drugs if targets are still missed after about 2 weeks of diet.
- Insulin is first-line; metformin is an alternative; glyburide is discouraged because it crosses the placenta.
- Deliver well-controlled disease at 39 weeks or later, and recheck glucose with a 75 g, 2-hour test 4–12 weeks after birth.
Why gestational diabetes develops, and why it matters
Pregnancy makes the mother progressively more resistant to insulin, helped along by signals from the placenta.[4][5]
Most women compensate by making more insulin. Gestational diabetes appears when they cannot: the beta cells fail to keep up.[4][5]
The risks to the pregnancy and the baby are:[2][4]
- macrosomia
- shoulder dystocia
- neonatal hypoglycaemia
- preeclampsia
- cesarean delivery
The mother also carries a higher risk of type 2 diabetes later.[2][4]
Gestational diabetes screening: the two-step test at 24–28 weeks
In the United States, screening is for everyone, at 24–28 weeks. ACOG Practice Bulletin 190 (2018) recommends two steps.[1][2][4]
- Step 1: the 50 g screenA 50 g glucose load, then a glucose level at 1 hour. A level of 130–140 mg/dL or higher, depending on the centre, is a positive screen.[2][5]
- Step 2: the confirmatory 100 g testA 100 g load, fasting, with glucose measured fasting, then at 1, 2 and 3 hours.[2][5]
A one-step alternative exists and is used in many other countries: a 75 g load with levels at fasting, 1 and 2 hours.[2][5][6]
Carpenter-Coustan limits: two or more abnormal values
The diagnosis is not one high number. With the Carpenter-Coustan cut-offs, two or more abnormal values on the 100 g test make the diagnosis.[2][4]
| Sample | Limit (mg/dL) |
|---|---|
| Fasting | 95 |
| 1 hour | 180 |
| 2 hours | 155 |
| 3 hours | 140 |
- Fasting 91 against a limit of 95: within the limit
- 1 hour 184 against a limit of 180: at or above the limit, abnormal
- 2 hours 151 against a limit of 155: within the limit
- 3 hours 126 against a limit of 140: within the limit
- One abnormal value is not enough, so this is not gestational diabetes
Early testing is only for high-risk patients
Testing earlier than 24–28 weeks is for patients at high risk of undiagnosed type 2 diabetes, such as obesity plus another risk factor.[3][4][6]
Gestational diabetes management, step 1: lifestyle and glucose targets
Once diagnosed, management is stepwise, and the first step is lifestyle. That means a dietitian, moderate walking after meals, and home glucose monitoring.[2][4]
| Time | Target |
|---|---|
| Fasting | below 95 mg/dL |
| 1 hour after meals | below 140 mg/dL |
| 2 hours after meals | below 120 mg/dL |
The targets are a fasting glucose below 95 and either below 140 at 1 hour or below 120 at 2 hours after meals.[4][7]
Step 2: insulin, metformin and glyburide
Drugs come second, if targets are still missed after about 2 weeks of diet.[2][4]
- Insulin is first-line, because it does not cross the placenta to any important degree and gives predictable control.[2][4][7]
- Metformin is an alternative, and many patients on it need insulin added.[2][4]
- Glyburide is discouraged, because it crosses the placenta and raises the risks of macrosomia and neonatal hypoglycaemia.[4]
Surveillance, delivery timing and the postpartum test
Patients treated with medication get fetal testing from 32 weeks.[2][4]
| Control | Delivery |
|---|---|
| Diet-controlled | 39 weeks to 40 weeks 6 days |
| Well controlled on medication | 39 weeks to 39 weeks 6 days |
After birth, glucose is rechecked with a 75 g, 2-hour test at 4–12 weeks, because diabetes may persist.[2][8]
Practice question
Original · USMLE styleA 31-year-old woman, gravida 2 para 1, comes for a prenatal visit at 27 weeks' gestation. She has no symptoms. A 50-g oral glucose challenge test last week showed a 1-hour plasma glucose of 158 mg/dL. She then had a 100-g oral glucose tolerance test, with the following plasma glucose values:
| Fasting | 108 mg/dL |
|---|---|
| 1 hour | 195 mg/dL |
| 2 hours | 146 mg/dL |
| 3 hours | 133 mg/dL |
Common questions
When is gestational diabetes screening done?
In the United States, everyone is screened at 24–28 weeks with the two-step approach: a 50 g load with a 1-hour glucose, then, if positive, a 100 g, 3-hour test to confirm.
What are the Carpenter-Coustan criteria?
On the 100 g test the limits are 95 mg/dL fasting, 180 at 1 hour, 155 at 2 hours and 140 at 3 hours. Two or more abnormal values make the diagnosis.
What is the first treatment for gestational diabetes?
Lifestyle: a dietitian, moderate walking after meals and home glucose monitoring. Drugs are added if targets are still missed after about 2 weeks of diet.
Is insulin or metformin used for gestational diabetes?
Insulin is the first-line drug because it does not cross the placenta to any important degree. Metformin is an alternative, and many patients on it need insulin added. Glyburide is discouraged.
When should gestational diabetes be delivered?
When glucose is well controlled, diet-controlled disease is delivered at 39 weeks to 40 weeks 6 days, and medication-controlled disease at 39 weeks to 39 weeks 6 days.
Transcript
Read the full narration, by chapter652 words
0:00The case: a large baby and no repeat glucose test
A woman has never had diabetes, her fasting glucose was normal at her first visit, and now, in the third trimester, her baby is measuring large. Her glucose was never checked again. Was something missed? What should have been done, and when? Today: screen for gestational diabetes, then step up treatment from lifestyle to drugs.
0:22Why it happens: insulin resistance, placental signals, the risks
Pregnancy makes the mother progressively more resistant to insulin, helped along by signals from the placenta. Most women compensate by making more insulin. Gestational diabetes appears when they cannot. The risks are macrosomia, shoulder dystocia, neonatal hypoglycaemia, preeclampsia and cesarean delivery. The mother also carries a higher risk of type two diabetes later.
0:50Step 1: the 50 g screen at 24 to 28 weeks
In the United States, screening is for everyone, at 24 to 28 weeks. ACOG Practice Bulletin 190, from 2018, recommends two steps. Step one: a 50-gram glucose load, and a glucose level at 1 hour. A level above 130 to 140 milligrams per decilitre, depending on the centre, is a positive screen.
1:15Step 2: the 100 g test and the Carpenter-Coustan limits
Step two, to confirm: a 100-gram load, fasting, with glucose at fasting, 1, 2 and 3 hours. With the Carpenter-Coustan cut-offs, the limits are 95, 180, 155, and 140. Two or more abnormal values make the diagnosis.
1:34The one-step alternative and a worked example
A one-step alternative exists, used in many other countries: a 75-gram load with levels at fasting, 1 and 2 hours. Let's try the 100-gram test. Fasting 91, 1 hour 184, 2 hours 151, 3 hours 126. Only the one-hour value crosses its limit. One abnormal value is not enough, so this is not gestational diabetes.
2:04Early testing for high-risk patients
Early testing is only for patients at high risk of undiagnosed type two diabetes, such as obesity plus another risk factor.
2:14Management step 1: lifestyle and the glucose targets
Once diagnosed, management is stepwise. First, lifestyle. That means a dietitian, moderate walking after meals, and home glucose monitoring. The targets are a fasting glucose below 95, and either below 140 at 1 hour or below 120 at 2 hours after meals.
2:35Management step 2: insulin, metformin, glyburide
Second, drugs, if targets are still missed after about two weeks of diet. Insulin is the first-line drug, because it does not cross the placenta to any important degree and gives predictable control. Metformin is an alternative, and many patients on it need insulin added. Glyburide is discouraged, because it crosses the placenta and raises the risks of macrosomia and neonatal hypoglycaemia.
3:02Surveillance, delivery timing and the postpartum test
Then surveillance and delivery. Patients treated with medication get fetal testing from 32 weeks. Diet-controlled gestational diabetes is delivered at 39 weeks to 40 weeks 6 days. Medication-controlled, at 39 weeks to 39 weeks 6 days. After birth, glucose is rechecked with a 75-gram two-hour test within 12 weeks, because diabetes may persist.
3:31Your turn: a practice question
Your turn. A 31-year-old woman, gravida two para one, is at 27 weeks. Her 50-gram glucose challenge gave a one-hour level of 158 mg/dL. On a 100-gram test, her glucose is one oh eight fasting, 195 at 1 hour, 146 at 2 hours, and 133 at 3 hours. She has no symptoms, and fetal growth is normal. Which is the most appropriate next step? A: dietary counselling and home glucose monitoring. B: basal insulin started this week. C: oral glyburide started this week. D: repeat 100-gram test in two weeks. E: induction of labour scheduled at 37 weeks.
4:24The answer, one option at a time
B is out: insulin is for targets missed despite diet, not for a new diagnosis. C is out: glyburide is discouraged, and drugs come second anyway. D is out: the diagnosis is already made. E is out: delivery is timed from 39 weeks, and nothing here calls for earlier. So the answer is A. Her fasting and one-hour values both exceed the Carpenter-Coustan limits, so she has gestational diabetes, and lifestyle comes first.
4:57Recap pocket card and next lesson
Three things to keep. One: screen at 24 to 28 weeks, 50 grams then a 100 grams, and two abnormal values diagnose. Two: lifestyle first; insulin if targets are missed after about two weeks. Three: deliver at 39 weeks or later, and retest after birth. Next, preeclampsia and its severe features.
Sources
Numbers in the text, e.g. [1], point here- ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstet Gynecol 2018;131:e49-e64 (as summarised by the sources below).
- MSD Manual Professional Version. Diabetes Mellitus in Pregnancy (updated Jul 2026). msdmanuals.com/professional/gynecology-and-obstetrics/pregnancy-complicated-by-disease/diabetes-mellitus-in-pregnancy
- MSD Manual Professional Version. Evaluation of the Obstetric Patient. msdmanuals.com/professional/gynecology-and-obstetrics/approach-to-the-pregnant-woman-and-prenatal-care/evaluation-of-the-obstetric-patient
- J Clin Endocrinol Metab 2024 review of gestational diabetes. europepmc.org/article/PMC/PMC11651698
- Int J Gen Med 2026, screening guidelines compared. europepmc.org/article/PMC/PMC13660840
- Cureus 2025, gestational diabetes management. europepmc.org/article/PMC/PMC11928751
- ADA Standards of Care 2025, Section 15 summary. europepmc.org/article/PMC/PMC12022456
- Postpartum testing: europepmc.org/article/PMC/PMC13299515 · europepmc.org/article/PMC/PMC13297138
The practice question is original and its patient is synthetic. Every fact is checked against the sources above in independent accuracy reviews. Always follow your local guidelines and your own laboratory’s ranges.
Image credits. Illustrations: Servier Medical Art (smart.servier.com), CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/), adapted (recoloured, outlined, resized): fetus in utero, normal location of placenta, pancreas islet of Langerhans, glucometer, syringe, blood pressure measurement. Nutrition icon: Health Icons (CC0). The glucose graphs, bottle, cell sketch, ribbon, slip, cards and all handwriting are drawn in code (original). No AI-generated teaching images.
Corrections. None so far. Spotted an error? Email info@medservatory.com with the lesson code MS-CK-OBGYN-006.
For exam study only, not medical advice. Read the medical disclaimer.
In this series
Playlist on YouTube- EP 01Prenatal screening timeline: what is done when in pregnancy5:23
- EP 02Ectopic pregnancy: beta-hCG, ultrasound, methotrexate vs surgery5:53
- EP 03Adnexal torsion: why normal Doppler does not rule it out5:31
- EP 04Gestational diabetes: screening, diagnosis and management5:25
- EP 05Preeclampsia: criteria, severe features, magnesium and delivery timing5:43
- EP 06Rh alloimmunisation and anti-D immunoglobulin: when to give RhIG5:49
- EP 07Placenta previa vs placental abruption5:43
- EP 08PROM vs PPROM: diagnosis and management by gestational age5:59
- EP 09Fetal heart rate decelerations: early, variable and late5:46
- EP 10Postpartum hemorrhage: the 4 Ts and first response5:46